Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
2,080.00    -62.00 (-2.89%)
Bid:
2,066.00
Ask:
2,070.00
Spread: 4.00 (0.194%)
Market Cap: £3.48b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Directorate Change

16 Apr 2018 07:25

RNS Number : 9451K
Johnson Matthey PLC
16 April 2018
 

Johnson Matthey Plc announces Patrick Thomas as Chairman Designate

 

The Board of Directors of Johnson Matthey Plc is pleased to announce that Patrick Thomas will succeed Tim Stevenson as Chairman.

 

Patrick will join the board as Non-Executive Director and Chairman Designate on 1st June 2018. He will be appointed as Chairman of the board with effect from the end of the Annual General Meeting on 26th July 2018 when Tim Stevenson retires, after seven years as Chairman.

 

Patrick has deep experience in leading international speciality chemicals businesses. He brings to Johnson Matthey an impressive track record of driving growth through science and innovation across global markets. Since 2015 Patrick has been Chief Executive Officer and Chairman of the Board of Management of Covestro AG, a world leading polymers business. Between 2007 and 2015 he was also Chief Executive Officer of its predecessor, Bayer MaterialScience, prior to its demerger from Bayer AG. Patrick will step down from his role at Covestro AG at the end of May 2018.

 

Before joining Bayer, Patrick spent five years with the global chemical company, Huntsman Corporation, including as President of its Polyurethanes, Performance and Advanced Materials divisions. Prior to this he was Chief Executive of ICI’s polyurethanes business and led its integration into Huntsman. In his earlier career, Patrick held a number of global and regional roles in ICI.

 

Patrick also has strong board experience. He is currently an independent non-executive director of Akzo Nobel N.V., the paints, coating and specialty chemicals group. He was previously an independent non-executive director and member of the Audit and Remuneration Committees of BG Group plc from December 2010 to February 2016.

 

Patrick’s background is in Engineering Science; he has an MA from Oxford University, is a Fellow of the Royal Academy of Engineering and a Fellow of the Institute of Engineering and Technology.

 

Commenting on Patrick’s appointment, Tim Stevenson, Chairman of Johnson Matthey, said:

 

"I am thrilled that the board has chosen Patrick to succeed me as Chairman. Patrick brings a valuable combination of extensive board experience and recent executive leadership of major global organisations. I am confident that he will successfully steer Johnson Matthey to deliver continued value for our shareholders as we pursue our vision to make the world a cleaner and healthier place."

 

Robert MacLeod, Chief Executive of Johnson Matthey, added:

 

"I am delighted to welcome Patrick as the future Chairman of Johnson Matthey and look forward to working with him as we deliver our growth strategy."

 

Commenting on his appointment, Patrick Thomas said:

 

“I am really excited to be joining Johnson Matthey, a company with a strong reputation for science and a great team of people. I am looking forward to joining the board as we continue to evolve and grow, creating value for our shareholders and for the world around us.”

 

 

Disclosures required pursuant to Rule 9.6.13 of the Listing Rules of the Financial Conduct Authority (including directorships held in other publicly quoted companies at any time in the previous five years):

 

Patrick was appointed as a non-executive director and member of the supervisory board of Akzo Nobel N.V. in November 2017, a company listed on the stock exchange of Euronext Amsterdam.

 

Since August 2015, Patrick has been Chief Executive Officer and Chairman of the Board of Management of Covestro AG, a company listed on the Frankfurt Stock Exchange.

 

From December 2010 to February 2016, Patrick was a non-executive director of BG Group Plc, a company listed on the London Stock Exchange.

 

Other than as stated in this announcement, there are no other disclosures required pursuant to Rule 9.6.13 of the Listing Rules of the Financial Conduct Authority.

 

Enquiries:

 

 

 

Analysts and investors:

 

Martin Dunwoodie

+44 (0)20 7269 8241

Simon McGough

+44 (0)20 7269 8235

Katharine Burrow

+44 (0)20 7269 8444

 

 

Media:

 

Sally Jones

+44 (0)20 7269 8407

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFMGMDLKRGRZG
Date   Source Headline
3rd Jun 20269:03 amRNSDirector/PDMR Shareholding
2nd Jun 20264:40 pmRNSDirector/PDMR Shareholding
1st Jun 20264:02 pmRNSHolding(s) in Company
28th May 20267:05 amRNSBoard Changes
28th May 20267:01 amRNSJohnson Matthey acquisition of Cormetech
28th May 20267:00 amRNSJohnson Matthey Full Year Results
14th May 202611:42 amRNSDirector/PDMR Shareholding
16th Apr 202611:51 amRNSDirector/PDMR Shareholding
24th Mar 202611:30 amRNSDirector/PDMR Shareholding
27th Feb 20267:00 amRNSDirector Declaration
24th Feb 20263:30 pmRNSDirector/PDMR Shareholding
24th Feb 20269:48 amRNSDirector/PDMR Shareholding
23rd Feb 20265:19 pmRNSDirector/PDMR Shareholding
23rd Feb 20267:00 amRNSUpdate on Catalyst Technologies sale
12th Feb 202612:44 pmRNSDirector/PDMR Shareholding
14th Jan 20262:22 pmRNSDirector/PDMR Shareholding
8th Jan 202610:01 amRNSHolding(s) in Company
30th Dec 20257:00 amRNSHolding(s) in Company
29th Dec 20257:00 amRNSHolding(s) in Company
29th Dec 20257:00 amRNSHolding(s) in Company
11th Dec 20254:51 pmRNSDirector/PDMR Shareholding
20th Nov 20257:00 amRNSDirectorate change
20th Nov 20257:00 amRNSJohnson Matthey Half Year Results
13th Nov 20257:00 amRNSDirector/PDMR Shareholding
24th Oct 202511:29 amRNSHolding(s) in Company
21st Oct 20253:44 pmRNSHolding(s) in Company
13th Oct 202511:55 amRNSDirector/PDMR Shareholding
9th Oct 20257:00 amRNSFinancial reporting structure and trading update
3rd Oct 202510:23 amRNSHolding(s) in Company
30th Sep 20257:00 amRNSHolding(s) in Company
26th Sep 20255:29 pmRNSHolding(s) in Company
17th Sep 20259:00 amRNSDirector Declaration
15th Sep 20252:37 pmRNSHolding(s) in Company
11th Sep 20254:13 pmRNSDirector/PDMR Shareholding
8th Sep 20256:00 pmRNSHolding(s) in Company
4th Sep 20255:19 pmRNSHolding(s) in Company
2nd Sep 20254:07 pmRNSHolding(s) in Company
29th Aug 202512:05 pmRNSTotal Voting Rights
26th Aug 20252:07 pmRNSDirector/PDMR Shareholding
13th Aug 20254:38 pmRNSDirector/PDMR Shareholding
13th Aug 20251:51 pmRNSDirector/PDMR Shareholding
5th Aug 20255:19 pmRNSHolding(s) in Company
5th Aug 20254:50 pmRNSDirector/PDMR Shareholding
25th Jul 20252:12 pmRNSHolding(s) in Company
23rd Jul 20252:23 pmRNSHolding(s) in Company
18th Jul 202512:07 pmRNSDirector/PDMR Shareholding
18th Jul 20259:18 amRNSHolding(s) in Company
17th Jul 20252:20 pmRNSResult of AGM
17th Jul 20257:00 amRNSAppointment of Andrew Cosslett as Chair
9th Jul 20254:48 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.